Collectively, considering the relevance of Ca2+ dyshomeostasis in neurodegeneration, the validation of new drugs toward STIM1 targets may result in successful treatment strategies for AD, PD, HD, ALS and stroke. The gene discussed is STIM1; the disease is Alzheimer disease.